Chairperson - Felicia Cosman, MD
Professor of Clinical Medicine
Columbia University College of Physicians and Surgeons
New York, New York
Medical Director, Clinical Research Center
Helen Hayes Hospital
West Haverstraw, New York
|
Felicia Cosman, MD, is Medical Director of the Clinical Research Center at Helen Hayes Hospital, West
Haverstraw, New York. She is also Professor of Clinical Medicine at Columbia University, New York.
Dr. Cosman is a graduate of Cornell University and Stony Brook Medical School, New York, and she completed
her residency and an endocrinology fellowship at Columbia Presbyterian Medical Center.
Dr. Cosman's research interests include studies on the causes of osteoporosis and how estrogen, SERMS, and vitamin D work as treatments for osteoporosis. Her major research focus is the use of teriparatide in combination with antiresorptive agents and in novel cyclic regimens in the treatment of severe osteoporosis. She is the recipient of research grants from the National Institutes of Health, the Department of Defense, and the National Multiple Sclerosis Society. She has published over 100 peer-reviewed articles in journals including The New England Journal of Medicine and Lancet. She is the author of What Your Doctor May Not Tell You About Osteoporosis and coeditor of Osteoporosis: An Evidence-Based Approach to the Prevention of Fractures.
Dr. Cosman is the review editor for, and serves on the editorial boards of, Osteoporosis International and Clinical Cases in Mineral and Bone Metabolism. In addition, she has served as Clinical Director of the National Osteoporosis Foundation since 1996. Dr. Cosman has been elected to the Castle-Connolly list of Top Doctors every year from 2000 to 2006, and she has been featured in best doctor listings in both New York Magazine and Hudson Valley Magazine. |
|
|
|
Nelson B. Watts, MD
Professor of Medicine
University of Cincinnati College of Medicine
Director, University of Cincinnati Bone Health and Osteoporosis Center
Cincinnati, Ohio
|
Nelson B. Watts, MD, is Professor of Medicine at the University of Cincinnati College of Medicine and Director of
the University of Cincinnati Bone Health and Osteoporosis Center in Ohio.
Dr. Watts received his medical degree from the University of North Carolina School of Medicine at Chapel Hill, North Carolina, completed his medical internship at the Medical College of Georgia in Augusta, and served a residency in internal medicine at Carolinas Medical Center, Charlotte, North Carolina. Additional postdoctoral training includes a fellowship in endocrinology at the University of North Carolina.
Dr. Watts' major research interest is osteoporosis, particularly the study of therapeutic agents and tests for diagnosis and monitoring. His contributions to the medical literature include more than 50 books and book chapters, and he has written well over 250 abstracts and articles for such journals as the Journal of the American Medical Association and The New England Journal of Medicine.
Dr. Watts currently serves as chair of the Food and Drug Administration's Advisory Committee for Endocrine and Metabolic Drugs and is on the ABIM Subspecialty Board on Endocrinology. He is also Associate Editor of the Journal of Clinical Densitometry, serves on the editorial boards of Osteoporosis International and the Journal of Clinical Endocrinology and Metabolism, and is active in several professional societies. Dr. Watts is past President of the American College of Endocrinology and International Society of Clinical Densitometry. |
|
|
Michael R. McClung, MD
Department of Medical Education
Providence Portland Medical Center
Director, Oregon Osteoporosis Center
Portland, Oregon
|
Michael R. McClung, MD, FACP, is the founding director of the Oregon Osteoporosis Center and serves as
Assistant Director in the Department of Medical Education at the Providence Portland Medical Center in
Portland, Oregon.
Dr. McClung received his medical degree at The University of Texas Southwestern Medical School in Dallas. He completed his internship and residency in Medicine at Parkland Memorial Hospital, also in Dallas.
Dr. McClung's special interests include disorders of skeletal and mineral metabolism, and he has served as the primary investigator for several multicenter clinical trials. He is active in several professional societies and has authored multiple scientific and clinical papers. |
|
|
Kenneth W. Lyles, MD
Professor of Medicine
Vice Chair for Clinical Research
Director, Medicine Site-Based Research
Duke University School of Medicine
VA Medical Center
Durham, North Carolina
|
Kenneth W. Lyles, MD, is Professor of Medicine, Vice Chair for Clinical Research and Director of Medicine
Site-Based Research at Duke University Medical Center (DUMC) in Durham, North Carolina. Additional
appointments include Director of the Geriatric Physician Fellowship Program, Clinical Director of Geriatric
Research, Education and Clinical Center, as well as Director of the Geriatric Evaluation and Management Unit at Durham VA Medical Center.
Dr. Lyles received his medical degree from the Medical College of Virginia in Richmond and completed an
internship and residency in internal medicine at the Medical College of Virginia Hospitals. Additional postgraduate training includes a fellowship in endocrinology and metabolism at DUMC and a fellowship in geriatrics and gerontology at Durham VA Medical Center and DUMC.
Dr. Lyles' research has focused on age-associated osteoporosis, glucocorticoid-induced osteoporosis, Paget's
disease of bone, and tumoral calcinosis. He has written extensively on these topics and others related to bone metabolism, having contributed close to 100 journal articles and 24 book chapters. A Fellow of the American College of Physicians, the Gerontological Society of America, and the American Geriatrics Society, Dr. Lyles is also an active member of several professional organizations and, since 1994, has held the position of Secretary- Treasurer of The Paget Foundation for Paget's Disease of Bone and Related Disorders. He also serves on the editorial boards of the American Journal of Geriatric Pharmacotherapy, Advances in Osteoporotic Fracture Management, Journal of the American Geriatrics Society, Journal of Gerontology: Medical Sciences, and Osteoporosis International. |
|
|
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the faculty for this activity have been asked to complete a Conflict of Interest Disclosure form. Disclosure is required to be provided to attendees or participants.
The following faculty members
disclosed program- or content-related
financial affiliations:
Felicia Cosman, MD
Dr. Cosman has received research/grant support from Eli
Lilly and Company. She serves as a consultant for Novartis Pharmaceuticals Corporation, Eli Lilly and Company, Merck & Co., Inc., Pfizer, and Roche, and is on the Speakers Bureau for Eli Lilly and Company, Merck & Co., Inc., and Roche.
Nelson B. Watts, MD
Dr. Watts has received research/grant support from
Amgen Inc., Eli Lilly and Company, MicroMRI,
Novartis Pharmaceuticals Corporation, Procter & Gamble, Radius, sanofi-aventis, and Solvay. He serves as
a consultant for Amgen Inc., Eli Lilly and Company, Kyphon, Novartis Pharmaceuticals Corporation, Procter
& Gamble, Roche, and sanofi-aventis. Dr. Watts has received honoraria for lectures from the following
companies, but is not a member of any formal speakers bureau: Amgen Inc., Novartis Pharmaceuticals
Corporation, Procter & Gamble, and sanofi-aventis.
Michael R. McClung, MD
Dr. McClung has received research/grant support from Amgen Inc., Eli Lilly and Company, Novartis
Pharmaceuticals Corporation, Procter & Gamble, and Roche. He is also a consultant for these same
companies, in addition to sanofi-aventis.
Kenneth W. Lyles, MD
Dr. Lyles has received research/grant support from Novartis Pharmaceuticals Corporation, The Alliance
for Better Bone Health, and Amgen Inc. He serves as a consultant for Novartis Pharmaceuticals
Corporation, Procter & Gamble, Merck & Co., Inc., Amgen Inc., GTx, and Bone Medical Limited. Dr. Lyles is
the use patent inventor of "Methods for preventing or reducing secondary fractures after hip fracture," US
Patent Application 20050272707, and the provisional patent application inventor for "Medication Kits and
Formulations for Preventing, Treating or Reducing Secondary Fractures After Previous Fracture. "
Dr. Lyles knowingly includes in his educational session the discussion of off-label or investigative uses of
commercial products.
|
|